NCT06000761 Frequent Standardized Oral Care Using Human Milk in the Neonatal Intensive Care Unit
| NCT ID | NCT06000761 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Florida |
| Condition | Ventilator Associated Pneumonia |
| Study Type | INTERVENTIONAL |
| Enrollment | 218 participants |
| Start Date | 2023-11-23 |
| Primary Completion | 2026-09-23 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 218 participants in total. It began in 2023-11-23 with a primary completion date of 2026-09-23.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Premature infants are susceptible to complications related to infrequent and non-standardized oral care. Although the benefits of frequent standardized oral care are known to reduce oral dysbiosis (increased level of potentially pathogenic bacteria) and its associated complications in critically ill adults leading to established evidence-based guidelines, no such information exists for VLBW infants. The proposed study will prospectively follow 168 VLBW infants for 4 weeks following birth.
Eligibility Criteria
Inclusion: * Mother ≥18 years of age * ≤ 30 weeks gestation * Born weighing ≤ 1500 grams Exclusion: * Congenital anomalies of the face, lungs, or gastrointestinal system * Not expected to live \> 7 days following delivery.
Contact & Investigator
Leslie Parker, PHD
PRINCIPAL INVESTIGATOR
University of Florida
Frequently Asked Questions
Who can join the NCT06000761 clinical trial?
This trial is open to participants of all sexes, aged 1 Hour or older, up to 3 Days, studying Ventilator Associated Pneumonia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06000761 currently recruiting?
Yes, NCT06000761 is actively recruiting participants. Contact the research team at parkela@ufl.edu for enrollment information.
Where is the NCT06000761 trial being conducted?
This trial is being conducted at Gainesville, United States.
Who is sponsoring the NCT06000761 clinical trial?
NCT06000761 is sponsored by University of Florida. The principal investigator is Leslie Parker, PHD at University of Florida. The trial plans to enroll 218 participants.